OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Release Date
2022
(1)
2021
(1)
2018
(1)
2014
(1)
2009
(1)
2008
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
Not available
S-EPMC4050205
|
biostudies-literature
Cite
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Not available
S-EPMC2651097
|
biostudies-literature
Cite
Setting research priorities to achieve long-term health targets in Iran.
Not available
S-EPMC6188089
|
biostudies-literature
Cite
Adjuvant chemotherapy in older women with early-stage breast cancer.
Not available
S-EPMC3082436
|
biostudies-literature
Cite
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856
|
biostudies-literature
Cite
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets